Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03528174 · ClinicalTrials.gov registry record · NA
Single Hormone Closed Loop Study With PDT Sensor
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03528174 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 10 participants.
The verdict
NCT03528174, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The study described within this protocol is designed to test a single hormone closed-loop algorithm for managing blood glucose in type 1 diabetes using insulin only and a new device for measuring glucose continuously in the immediate vicinity of subcutaneous insulin delivery. Subjects will undergo one all day closed loop study using insulin only. The closed loop insulin only system includes a Dexcom G5 transmitter, a Nexus 5 smart phone and two Tandem tslim pumps connected to two Pacific Diabetes Technologies glucose sensing cannulas. The closed loop system will be started after G5 2 hour sensor start-up with an IV catheter for frequent blood withdrawal for 10 hours.
Interventions
- DEVICE Artificial Pancreas Control system (APC)
- DEVICE Pacific Diabetes Technologies CGM Insulin Infusion system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-04-16 |
| Est. Completion | 2018-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03528174
The ClinicalTrials.gov registry entry for NCT03528174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Artificial Pancreas Control system (APC) is the first listed.
NCT03528174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03528174 about?
NCT03528174 is a clinical study titled "Single Hormone Closed Loop Study With PDT Sensor". The study described within this protocol is designed to test a single hormone closed-loop algorithm for managing blood glucose in type 1 diabetes using insulin only and a new device for measuring glucose continuously in the immediate vicinity of subcutaneous insulin delivery. Subjects will undergo o...
What is the current status of trial NCT03528174?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-04-16. Estimated completion is 2018-07-01.
What interventions are being tested in trial NCT03528174?
The interventions under investigation include: Artificial Pancreas Control system (APC) (DEVICE), Pacific Diabetes Technologies CGM Insulin Infusion system (DEVICE).
Who is sponsoring clinical trial NCT03528174?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.